Developed by BNC Korea in 2007, Bienox offers a highly purified form of Clostridium Botulinum Toxin Type A. Its products address moderate to severe facial wrinkles and muscle-related conditions. Each vial contains 100 units of the active toxin, accompanied by human serum albumin and sodium chloride as excipients. The lyophilized powder requires reconstitution with sterile, preservative-free 0.9% sodium chloride solution before administration. Bienox has gained recognition for its efficacy and safety in both cosmetic and therapeutic applications.